These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 30103858)
1. Physicochemical characterisation in drug discovery. Balogh GT Drug Discov Today Technol; 2018 Jul; 27():1-2. PubMed ID: 30103858 [No Abstract] [Full Text] [Related]
2. Principles and applications of Raman spectroscopy in pharmaceutical drug discovery and development. Gala U; Chauhan H Expert Opin Drug Discov; 2015 Feb; 10(2):187-206. PubMed ID: 25399993 [TBL] [Abstract][Full Text] [Related]
4. Physicochemical descriptors of aromatic character and their use in drug discovery. Ritchie TJ; Macdonald SJ J Med Chem; 2014 Sep; 57(17):7206-15. PubMed ID: 24856517 [TBL] [Abstract][Full Text] [Related]
6. Advances in Mass Spectrometry Within Drug Discovery. Wingfield J; Wilson ID J Biomol Screen; 2016 Feb; 21(2):109-10. PubMed ID: 26773070 [No Abstract] [Full Text] [Related]
7. Predictive DMPK: in silico ADME predictions in drug discovery. Kenny JR Mol Pharm; 2013 Apr; 10(4):1151-2. PubMed ID: 23540938 [No Abstract] [Full Text] [Related]
8. The influence of the 'organizational factor' on compound quality in drug discovery. Leeson PD; St-Gallay SA Nat Rev Drug Discov; 2011 Sep; 10(10):749-65. PubMed ID: 21959288 [TBL] [Abstract][Full Text] [Related]
9. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement. Murdande SB; Pikal MJ; Shanker RM; Bogner RH Pharm Dev Technol; 2011 Jun; 16(3):187-200. PubMed ID: 20429826 [TBL] [Abstract][Full Text] [Related]
10. How do we optimize chemical space navigation? Vogt M Expert Opin Drug Discov; 2020 May; 15(5):523-525. PubMed ID: 32067507 [No Abstract] [Full Text] [Related]
11. Overview of determination of biopharmaceutical properties for development candidate selection. Yazdanian M Curr Protoc Pharmacol; 2013 Mar; Chapter 9():Unit9.17. PubMed ID: 23456615 [TBL] [Abstract][Full Text] [Related]
12. Drug discovery: a research sector stricken in France that can sometimes pay off. Kraus JL Drug Discov Today; 2019 Jun; 24(6):1229-1231. PubMed ID: 31075316 [No Abstract] [Full Text] [Related]
13. A Special Section on Pharmaceutical Nanotechnology: Development of Soft Nanoparticles and Their Biological Evaluations. Pohlmann Adriana R ; Lemos-Senna Elenara J Nanosci Nanotechnol; 2016 Feb; 16(2):1235-7. PubMed ID: 27433572 [No Abstract] [Full Text] [Related]
15. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates. Palucki M; Higgins JD; Kwong E; Templeton AC J Med Chem; 2010 Aug; 53(16):5897-905. PubMed ID: 20527889 [No Abstract] [Full Text] [Related]
17. Editorial: The Expanding Landscape of Graph Theoretic Molecular Descriptors: Development, Gradual Diversification of Descriptor Space, and Applications in QSAR/ QMSA and New Drug Discovery. Basak SC Curr Comput Aided Drug Des; 2017; 13(3):172-176. PubMed ID: 29517467 [No Abstract] [Full Text] [Related]
18. Updating molecular properties during early drug discovery. Caron G; Ermondi G Drug Discov Today; 2017 Jun; 22(6):835-840. PubMed ID: 27890670 [TBL] [Abstract][Full Text] [Related]
19. Small molecules and their role in effective preclinical target validation. Clegg MA; Tomkinson NC; Prinjha RK; Humphreys PG Future Med Chem; 2017 Sep; 9(14):1579-1582. PubMed ID: 28828889 [No Abstract] [Full Text] [Related]
20. Overview of chemical diversity. Triggle DJ Curr Protoc Pharmacol; 2001 May; Chapter 9():Unit 9.1. PubMed ID: 21971814 [No Abstract] [Full Text] [Related] [Next] [New Search]